SkBr3 (also known as SK-BR-3) is a human breast cancer cell line isolated by the Memorial Sloan–Kettering Cancer Center in 1970 that is used in therapeutic research, especially in …

SK-BR-3 [SKBR3] cells were isolated in 1970 from pleural effusion cells of a 43-year-old, White, female adenocarcinoma patient with blood type A+ who had been treated with radiation, …

2025年3月18日 · SKBR3 cells have played a significant role in breast cancer research, particularly in understanding HER2-positive tumors. As a widely studied human breast cancer …

Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. From: Memorial Sloan Kettering Cancer Center; New York; USA. …

The metastatic SKBR3 cell-membrane proteome revealed a broad and rich map of receptors, immune response, adhesion and transporter proteins that sustain cancer-cell interactions with …

Initially, well-established breast cancer cell lines, namely SKBR3 and BT474 [9], were used to mimic the in vitro conditions representative of HER2-positive breast cancer. Optimal …

SK-BR-3 is a human breast cancer cell line that overexpresses the Her2 (Neu/ErbB-2) gene product. These cells display an epithelial morphology in tissue culture and are capable of …

2019年4月15日 · Loss of BRCA1 sensitizes cells to ZMC1. a Schematic representation of the mechanisms of ZMC1 reactivating mutant p53 R175H. b The survival of breast cancer cell line …

Cell Line: SK-BR-3, Established from pleural effusion tumor cells of a 43-year-old Caucasian female patient with breast adenocarcinoma.

2024年8月28日 · The proteomic analysis of SKBR3/HER2+ breast cancer cells treated with the EGFR/ERBB2 receptor Tyr kinase inhibitor Lapatinib and pan-AKT Ser/Thr kinase inhibitor …